Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer

Genes(2023)10.3390/genes14030607Source: DataRank Database

NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer is a research paper published in Genes (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.19)OA: goldTopics (61)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Michael A. Boatman,Iván Martínez ORCID,Julia H. Carter ORCID,Erik A. Bey ORCID,Brian Madajewski ORCID

Live enrichment

PubMed:36980879 PMC:PMC10047941 OpenAlex:https://openalex.org/W4322628977

WVCTSI-NIH-NIGMS

Grant: U54 GM104942

WVCTSI-NIH-NIGMS

Grant: IRG-09-061-04

NCI NIH HHS

Grant: P30 CA008748

National Institutes of Health

Grant: 2U54GM104942-02

West Virginia Clinical and Translational Science Institute: Improving Health through Partnerships and Transformative Research

FWCI

1.19

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4425/14/3/607/pdf?version=1677571949

publisherhttps://www.mdpi.com/2073-4425/14/3/607/pdf?version=1677571949

publisherhttps://www.mdpi.com/2073-4425/14/3/607/pdf

journalhttps://doi.org/10.3390/genes14030607

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36980879

Fields of Study

Bioactive Compounds and Antitumor AgentsGenomics, phytochemicals, and oxidative stressCancer therapeutics and mechanisms03 medical and health sciences0302 clinical medicineHumansCarcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmLung NeoplasmsNADNAD(P)H Dehydrogenase (Quinone)NADH, NADPH OxidoreductasesQuinonesA549 CellsBenzoquinones

MeSH Terms

A549 CellsCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsNADNADH, NADPH OxidoreductasesQuinonesBenzoquinonesNAD(P)H Dehydrogenase (Quinone)Drug Resistance, Neoplasm

Keywords

Cancer researchNAD+ kinaseDrug resistanceCisplatinSpheroidLung cancerBiologyApoptosisCancerPhenotypeCell cultureMedicineChemotherapyEnzymeOncologyBiochemistryGeneGeneticsProliferationNon-small cell lung cancerself-renewalSpheroidsTumor-initiating CellsNqo1Chemo-resistanceLung NeoplasmsQuinonesNADArticleDrug Resistance, NeoplasmA549 CellsCarcinoma, Non-Small-Cell LungNAD(P)H Dehydrogenase (Quinone)BenzoquinonesHumansNADH, NADPH Oxidoreductases

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being